Peter Rigsby

Evaluation of a candidate international standard preparation for human anti-Toxoplasma immunoglobulin G.

Evaluation of adenyl cyclase toxin constructs from Bordetella pertussis as candidate vaccine components in an in vitro model of complement-dependent intraphagocytic killing.

Investigation in a model system of the effects of combinations of anthrax and pertussis vaccines administered to service personnel in the 1991 Gulf War.

Evaluation of the saccharide content and stability of the first WHO International Standard for Haemophilus influenzae b capsular polysaccharide.

A retrospective study on the quality of Haemophilus influenzae type b vaccines used in the UK between 1996 and 2004.

RETRACTED: Evaluation of two Human plasma pools as candidate International Standard Preparations for syphilitic antibodies.

An improved method for development of toxoid vaccines and antitoxins.

Transferability of dermal temperature histamine sensitization test for estimation of pertussis toxin activity in vaccines.

Evaluation of two human plasma pools as candidate international standard preparations for syphilitic antibodies.

Development and use of a novel in vitro assay for testing of diphtheria toxoid in combination vaccines.

Immunogenicity and thermal stability of a combined vaccine against Haemophilus influenzae type b and Neisseria meningitidis serogroup C diseases.

Collaborative study for the calibration of a replacement international standard for diphtheria toxoid adsorbed.

EUVAC.NET collaborative study: evaluation and standardisation of serology for diagnosis of pertussis.

Collaborative study for the calibration of a replacement International Standard for Tetanus Toxoid Adsorbed.

A functional dual-coated (FDC) microtiter plate method to replace the botulinum toxin LD50 test.

Evaluation of an in vitro assay system as a potential alternative to current histamine sensitization test for acellular pertussis vaccines.

In vitro antigen ELISA for quality control of tetanus vaccines.

Calibration and commutability assessment of the 1st International Standard for Diphtheria Antitoxin Human.

A novel enzyme-linked immuno-sorbent assay (ELISA) for the quantification of total and free polysaccharide in Haemophilus influenzae b-Tetanus toxoid conjugate vaccines in monovalent and combined vaccine formulations.

Establishment of replacement International Standard 13/132 for human antibodies to Toxoplasma gondii.

Collaborative study for the calibration of a replacement International Standard for diphtheria toxoid for use in flocculation test.

Establishment of the first WHO International Standard for etanercept, a TNF receptor II Fc fusion protein: Report of an international collaborative study.

Establishment of the World Health Organization 2 International Standard for Factor XI, Plasma, Human.

Evaluation of candidate international standards for meningococcal serogroups A and X polysaccharide.

International standards for monoclonal antibodies to support pre- and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities of rituximab.

Recommendations of the VAC2VAC workshop on the design of multi-centre validation studies.

Establishment of the World Health Organization First International Standard for Factor XII, Plasma, Human.

Establishment of the 1st WHO International Standard for anti-EV71 serum (Human).

WITHDRAWN: Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG.

Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG.

Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study.

The first World Health Organization International Standard for infliximab products: A step towards maintaining harmonized biological activity.

Evaluation of two WHO First International Standards for Vi polysaccharide from Citrobacter freundii and Salmonella enterica subspecies enterica serovar Typhi.

Establishment of the WHO 2nd International Standard Factor V, plasma (16/374): communication from the SSC of the ISTH.

Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays.

Comparison of Volumetric and Bead-Based Counting of CD34 Cells by Single-Platform Flow Cytometry.

Continued provision of WHO International Standards for total and free PSA: Content and commutability of replacement preparations.

The third international standard for anti-D immunoglobulin: international collaborative study to evaluate candidate preparations.

Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus.

A new WHO reference reagent for activated blood coagulation factor X (FXa), human (15/102).

Evaluation of a capture antigen ELISA for the characterisation of tetanus vaccines for veterinary use.

A WHO Reference Reagent for lupus (anti-dsDNA) antibodies: international collaborative study to evaluate a candidate preparation.

Harmonization of Zika neutralization assays by using the WHO International Standard for anti-Zika virus antibody.

Expansion of the 1st WHO international standard for antiserum to respiratory syncytial virus to include neutralisation titres against RSV subtype B: An international collaborative study.

The first World Health Organization International Standard for in vitro biological activity of darbepoetin.

An international collaborative study to establish the WHO 4th International Standard for Streptokinase: Communication from the SSC of the ISTH.

The Use of Next-Generation Sequencing for the Quality Control of Live-Attenuated Polio Vaccines.

Evaluation of a standardised Vi poly-l-lysine ELISA for serology of Vi capsular polysaccharide antibodies.

Establishment of a WHO Reference Reagent for anti-Mullerian hormone.

Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies.

Development of the first reference antibody panel for qualification and validation of cytokine release assay platforms - Report of an international collaborative study.

Saccharide dosage content of meningococcal polysaccharide conjugate vaccines determined using WHO International Standards for serogroup A, C, W, Y and X polysaccharides.

An international collaborative study to establish the WHO 3rd International Standard for Thrombin: Communication from the ISTH SSC subcommittee on factor XIII and fibrinogen.

The First WHO International Standard for Adalimumab: Dual Role in Bioactivity and Therapeutic Drug Monitoring.

Quantitation of thrombin-activatable fibrinolysis inhibitor in human plasma by isotope dilution mass spectrometry.

An international collaborative study to assign value for Total Factor XIII-B Subunit Antigen to the WHO 1st International Standard for Factor XIII Plasma, (02/206): Communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen.

The First WHO International Standard for Harmonizing the Biological Activity of Bevacizumab.

International collaborative study to evaluate and calibrate two recombinant L chain Ferritin preparations for use as a WHO International Standard.

Assessing the Variability of Cell-Associated HIV DNA Quantification through a Multicenter Collaborative Study.

Collaborative study for the calibration of a replacement International Standard for Diphtheria Antitoxin Equine.